VIVANI MEDICAL INCVANI
ASignal's systematic analysis rates VANI as Bearish.
Reflects the latest available analysis · analyzed Oct 23, 2026
The case on VANI
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Current ratio of 3.25x indicates strong short-term liquidity
- Cash position exceeds total debt, suggesting near-term financial runway
- Price near Bollinger Lower Band (1.0876), potentially indicating oversold conditions
- Negative RSI (30.56) indicating bearish momentum
- MACD below signal line with negative histogram, confirming downtrend
- Negative price momentum and trading below both SMA20 and SMA50
- Negative return on equity (-220.41%) and return on assets (-48.47%)
- Negative operating and free cash flow (-$25.3M and -$16.83M respectively)
- Extremely high beta (3.30x) indicating high volatility and risk
See the full verdict on VANI
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes VANI
Most investors never get a second opinion, let alone several. ASignal runs VANI past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.